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 Patient: Male, 46-year-old
 Final Diagnosis: Varicella zoster virus infection
 Symptoms: Abdominal and/or epigastric pain
 Medication: —
 Clinical Procedure: Biopsy
 Specialty: Cardiology • Gastroenterology and Hepatology • Infectious Diseases • Transplantology
 Objective: Rare disease
 Background: Acute pancreatitis is rare following solid organ transplantation but is associated with high mortality. It has been 
most commonly reported following renal transplant but can occur with other solid organ transplantations.
 Case Report: A 46-year-old male who had an orthotopic heart transplant 6 months ago presented with a 3-week history of 
abdominal pain. The patient described it as intermittent, sharp, and stabbing, originating in the periumbili-
cal area and radiating to the back. His lipase was elevated at 232 U/L. Given that the patient’s symptoms and 
lipase were elevated to greater than three times the upper limit of normal, he patient was diagnosed with 
acute pancreatitis. The patient also mentioned a diffuse itchy rash that started a few days prior to admission. 
Dermatology was consulted, and given the man’s clinical presentation, there was concern for atypical reacti-
vation of varicella zoster virus (VZV). VZV polymerase chain reaction of the vesicles returned positive. The pa-
tient was started on acyclovir and his symptoms improved.
 Conclusions: This is the first reported case of VZV-associated pancreatitis in a heart transplant patient. Our patient present-
ed with acute pancreatitis and was treated supportively. However, he did not receive antiviral treatment un-
til his rash was discovered. Timely treatment of VZV resulted in resolution of both the rash and pancreatitis. 
Timely diagnosis of pancreatitis and VZV is important to prevent development of multiorgan failure and death.
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Background
Acute pancreatitis is rare following solid organ transplantation 
but is associated with high mortality [1]. It has most commonly 
been reported following renal transplant, with an incidence 
ranging from 2% to 7% and a 50% to 100% mortality rate [2]. 
Acute pancreatitis is known to occur after heart transplanta-
tion, especially in the early postoperative period [3]. Given the 
high morbidity and mortality associated with such cases, early 
recognition and identification of a reversible etiology remains 
key. Common etiologies of pancreatitis in immunocompetent pa-
tients include gallstones, alcohol use, and medications. Among 
solid organ transplant recipients who are immunosuppressed, 
specific etiologies such as steroid use, azathioprine, and cyto-
megalovirus (CMV) reactivation have also been reported [1]. 
While only a few cases of pancreatitis in renal transplant pa-
tients have been attributed to VZV, some patients became 
critically ill and died from disseminated disease [4]. Here, we 
present the first reported case of acute pancreatitis associat-
ed with atypical reactivation of VZV presenting as a varicella-
like rash in a heart transplant recipient.
Case Report
A 46-year-old male with a history of non-ischemic dilated car-
diomyopathy who had an orthotopic heart transplant 6 months 
prior presented with a 3- week history of abdominal pain. 
The patient thought the pain was from lifting, but it had got-
ten progressively worse over the last few days. Other medical 
history included chronic obstructive pulmonary disorder, pul-
monary sarcoidosis, hypertension, and diabetes. At the time 
of presentation, the patient was on triple immunosuppres-
sion with mycophenolate mofetil, tacrolimus, and prednisone.
The patient described his abdominal pain as intermittent, sharp, 
and stabbing, originating in the periumbilical area and radi-
ating to the back. Associated symptoms included decreased 
oral intake, nausea, and vomiting. Work-up in the emergency 
department 3 days prior for mild abdominal pain included a 
computed tomography scan of the abdomen, which revealed 
no evidence of pancreatitis, cholecystitis, colitis, hydronephro-
sis, or gallstones. During the patient’s current hospitalization, 
his blood alcohol and triglyceride levels were within normal 
limits. His blood lipase was elevated at 232 U/L, uptrending 
from 130 U/L 3 days previously. Given the patient’s symptoms 
and lipase being elevated to greater than three times the up-
per limit of normal, he was diagnosed with acute pancreatitis.
The patient was admitted to the inpatient service and was 
in mild-moderate distress from the abdominal pain. He was 
started on supportive care for acute pancreatitis with intrave-
nous fluids and opioids for pain control. An abdominal ultra-
sound showed no evidence of gall stones, or gallbladder wall 
thickening. The etiology of the pancreatitis remained unclear. 
The patient’s steroid dose was halved and atorvastatin was 
discontinued in case it was contributory.
The patient mentioned an itchy rash over his body that start-
ed a few days prior to admission and had progressed since. 
The rash was noted to be vesicular, erythematous, diffuse on 
his neck, back, and groin, and present on both sides of the 
midline (Figure 1A). He denied sick contacts and reported a re-
mote history of chicken pox. A review of previous records dem-
onstrated presence of pre-transplant immunoglobulin G (IgG) 
varicella zoster virus (VZV) antibodies. Dermatology was con-
sulted and described the lesions as vesicles on an erythema-
tous base with no dermatomal distribution (Figure 1B). Given 
that the lesions were in multiple stages of development, there 
was concern for atypical reactivation of VZV that appeared 
Figure 1.  Non-dermatomal distribution of rash over back in various stages of healing (A). Close-up of vesicular lesions on 
erythematous base (B).
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more like varicella than herpes zoster in the setting of im-
munosuppression. The vesicles were swabbed for VZV poly-
merase chain reaction (PCR testing), which returned positive. 
A Tzanck smear showed giant multinucleated keratinocytes, 
confirming the PCR findings. VZV PCR and both VZV immuno-
globulin M (IgM) and IgG antibodies tested positive in blood. 
CMV and herpes simplex virus PCR were negative.
The patient was started on acyclovir 10 mg/kg q8h for 7 to 10 
days and placed on airborne precaution within hours of suspi-
cion for disseminated VZV. His symptoms improved with contin-
ued supportive care for pancreatitis. After the lesions crusted 
over, the patient was transitioned to oral valacyclovir to com-
plete a 10-day course. He was discharged and followed up in 
transplant clinic, where the symptoms had completely resolved 
and lipase levels were back within normal limits (31 U/L). He 
continues to have an uneventful post-transplant course.
Discussion
To our knowledge, this is the first reported case of VZV-
associated pancreatitis in a heart transplant patient. Our pa-
tient presented with a subtle rash that appeared more like VCV 
than HZV despite the prior history of chickenpox. Incidence 
of pancreatitis among heart transplant recipients can range 
from 2% to 18%, significantly higher than for other cardiac 
procedures [5]. However, the diagnosis may be delayed due 
to subtler clinical presentations and the potentially large dif-
ferential diagnoses for abdominal pain post solid organ trans-
plant. While gallstones and alcohol intake are the most com-
mon causes, other etiologies in immunocompromised patients, 
such as drugs or opportunistic infections, must be entertained.
Our patient met the Atlanta criteria for pancreatitis based 
on his lipase level and clinical presentation although his im-
aging was negative. Nearly all common etiologies of pancre-
atitis were ruled out in this patient; however, his symptoms 
did not begin to resolve until he initiated antiviral treatment 
for VZV. Although VZV may not be an irrefutable cause of his 
pancreatitis, the association between VZV and visceral organ 
involvement in immunosuppressed patients has been doc-
umented in the literature and should not be overlooked. In 
nearly all cases, the presentation of visceral involvement pre-
ceded the VZV rash, and a delayed diagnosis of VZV resulted 
in organ failure and death [6]. A study by Locksley et al. on 
VZV infection in bone marrow transplant recipients found that 
21% had visceral symptoms before skin manifestations [7]. 
Table 1.  A review of disseminated VZV cases predominantly reported in renal transplant patients in the past.
Study Patients Outcomes Conclusions
Metanalysis 1985–2011
Rommelaere et al. [10]
56 adult renal transplant 
patients with disseminated 
VZV
Mortality rate: 47% before 
1995 and 17% after 1995
Complications: 2/3 with 
disseminated intravascular 
coagulation
Disseminated VZV is life 
threatening but the mortality 
rate has decreased since 1995
Seropositive VZV patients with 
disseminated infection can still 
have fatal outcome
Single center retrospective 
study
Mustapic et al. [11]
40 renal transplant patients, 
5 of which had disseminated 
VZV
No deaths
Complications: 7 with 
cutaneous scarring, 2 with 
post-herpetic neuralgia, and 
5 relapsed.
Immunosuppression was 
decreased for the relapsed 
patients
Frequency and intensity of VZV 
infections is associated with 
degree of immunosuppression, 
particularly MMF
High-dose acyclovir and reduction 
of immunosuppression is 
important for treatment
Retrospective study 
2003–2013
Chitasombat et al. [12]
22 renal transplant patients 
with disseminated VZV
No deaths
All were treated with systemic 
acyclovir for 3–31 days.
Immunosuppression reduced 
for 59% of patients
Incidence of disseminated VZV 
post kidney transplant is low
Treatment with IV acyclovir and 
reduction of immunosuppression 
provides a favorable outcome in 
resource limited environments
Single center 
case report series
Fehr et al. [13]
4 renal transplant patients 
with disseminated VZV
No deaths
Complications: hepatitis, 
pneumonitis, disseminated 
intravascular coagulation
Further literature search reveals a 
high mortality rate of 34% but this 
has decreased in the recent years
High-dose acyclovir is the drug of 
choice
VZV – varicella zoster virus.
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Cases of VZV-induced pancreatitis have been described in im-
munocompetent patients as well [8].
This case and other similar cases presented previously in renal 
transplant patients (Table 1) reinforce the importance of pre-
venting VZV infection in immunocompromised patients [10–13]. 
Our patient had prior immunity to varicella, as evidenced by 
a reactive VZV IgG antibody, but interestingly, presented with 
what appears to be VZV despite no recent sick contacts with 
positive IgM and IgG serology. IgM serology can provide evi-
dence for a recent active VZV infection, but does not discrim-
inate between a primary infection and reinfection or reactiva-
tion of latent infection due to transient increase in specific IgM 
antibodies on such re-exposure to VZV. Thus, we hypothesize 
that our patient likely represents a case of VZV reactivation from 
previous latency. In general, all potential transplant patients 
should undergo serologic testing and seronegative patients 
should be vaccinated prior to the surgery [9]. Those who are 
not vaccinated and are exposed post-transplant should receive 
VZV immunoglobulin or acyclovir [9]. Therapy with acyclovir or 
alternative equivalent antiviral therapies should be initiated 
within 24 to 72 hours of symptom onset to maximize efficacy.
Conclusions
In summary, timely diagnosis of pancreatitis in the setting of 
disseminated VZV is important in immunocompromised pa-
tients to prevent development of multiorgan failure and death. 
Identification of the appropriate etiology for pancreatitis in post-
transplant patients requires maintaining a high suspicion for 
alternative diagnosis beyond conventional known risk factors.
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